We have located links that may give you full text access.
Comparative Study
Journal Article
Multicenter Study
Prostate cancer diagnosed after initial biopsy with atypical small acinar proliferation suspicious for malignancy is similar to cancer found on initial biopsy.
Urology 2002 November
OBJECTIVES: To compare matched clinical and prostatectomy data between (a) men with an initial biopsy diagnosis of atypical small acinar proliferation (ASAP) suspicious for malignancy whose cancer was diagnosed subsequently, and (b) men with a cancer diagnosis not preceded by an ASAP diagnosis. ASAP diagnoses apply to 1.5%-9.0% of prostatic biopsies and predict definite cancer in about 45% of repeat biopsies.
METHODS: At our hospitals, during overlapping intervals from 1990 to 2001, 7081 men underwent prostate biopsy, and 227 (3.2%) had an overall diagnosis (based on all cores sampled) of ASAP. We concurred with the ASAP diagnosis in 184 cases (81%). Repeat biopsy was performed in 129 (57%), with 22 again having ASAP and 51 (40%) adenocarcinoma. Nineteen men underwent prostatectomy at our hospitals. The controls comprised men who underwent prostatectomy before and after each man with an initial ASAP diagnosis (2:1 match with cases). Findings included grade, pathologic stage, measured maximum dimension of tumor, resection margin status, patient age, and latest preoperative serum prostate-specific antigen.
RESULTS: Men in the initial-ASAP group did not differ significantly from controls with respect to age (63 vs. 61, P = 0.08). Initial-ASAP and control groups had serum prostate-specific antigen levels of 5.9 and 7.4 ng/mL (P = 0.32), respectively; mean Gleason scores were 6.2 and 6.6 (P = 0.11); mean stages were pT2b and pT2b; and tumor size averaged 0.9 and 1.2 cm (P = 0.36). Fewer men with initial-ASAP diagnosis on biopsy had positive margins (5%) than did those in the control group (30%, P < 0.05).
CONCLUSIONS: An ASAP diagnosis represents undersampled cancer in at least 40% of cases and places men at risk of prostate cancer with similar clinicopathologic findings as in other men with cancer.
METHODS: At our hospitals, during overlapping intervals from 1990 to 2001, 7081 men underwent prostate biopsy, and 227 (3.2%) had an overall diagnosis (based on all cores sampled) of ASAP. We concurred with the ASAP diagnosis in 184 cases (81%). Repeat biopsy was performed in 129 (57%), with 22 again having ASAP and 51 (40%) adenocarcinoma. Nineteen men underwent prostatectomy at our hospitals. The controls comprised men who underwent prostatectomy before and after each man with an initial ASAP diagnosis (2:1 match with cases). Findings included grade, pathologic stage, measured maximum dimension of tumor, resection margin status, patient age, and latest preoperative serum prostate-specific antigen.
RESULTS: Men in the initial-ASAP group did not differ significantly from controls with respect to age (63 vs. 61, P = 0.08). Initial-ASAP and control groups had serum prostate-specific antigen levels of 5.9 and 7.4 ng/mL (P = 0.32), respectively; mean Gleason scores were 6.2 and 6.6 (P = 0.11); mean stages were pT2b and pT2b; and tumor size averaged 0.9 and 1.2 cm (P = 0.36). Fewer men with initial-ASAP diagnosis on biopsy had positive margins (5%) than did those in the control group (30%, P < 0.05).
CONCLUSIONS: An ASAP diagnosis represents undersampled cancer in at least 40% of cases and places men at risk of prostate cancer with similar clinicopathologic findings as in other men with cancer.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app